Drug Treatment - A Comprehensive Report for the UK Police

Transcription

1 Drug treatment performance summary CCG Board January 214

2 Prevalence 3, 2, 1, opiate and/or crack.. upper & lower CI's Prevalence of crack and opiate use is down Similar to the national average of 53%, the proportion 's problematic drug users in treatment in 213/14: 52% Source: PHE/NDTMS, 213 (DOMES report 212/13 Quarter 1)

3 Profile of clients in drug treatment 25% are women The percentage living with children 14% A breakdown of which is very similar to population, the largest ethnicity groups were white British 33% other white 23% black Caribbean 12% The proportion aged % Source: PHE/NDTMS, 213 (Quarterly performance report 212/13 Quarter 4

4 Dual diagnosis Proportion of drug treatment clients with dual diagnosis 212/13, and London 35% 3% 24% The number attending dual diagnosis service in 212/ % London

5 PHOF outcomes: successful treatment completions = % completed treatment and did not re-present Opiates 13% 8% England Non-opiates 31% 4% England All drugs 21% 15% England Overall higher than England but fares worse for non opiates (mainly crack and cannabis) Source: PHE/NDTMS, 213 (DOMES Q1)

6 Length of time in treatment Opiate clients in treatment more than 6 years: % of all opiate clients, 1/4/213-3/6/213, and England Local 15% National average 23.% Average time in treatment for all opiate users average in 2.8 years non opiate users:.9 years % 1% 2% 3% 4% Source: PHE/NDTMS, 213 (DOMES report 212/13 Quarter 1)

7 Blood borne virus tests and vaccinations HBV vaccinations: The proportion who have started a course of vaccination (year to date),, London, England Q1 213/14 National 19% There are also issues in regards to HEP C treatment London 34% 46% not available Hep C tests: The proportion who had a test year to date,, London, England Q1 213/14 % 1% 2% 3% 4% 5% 6% National 73% comparatively better at Hep B vaccinations but worse on Hepatitis C tests London 62% 68% % 1% 2% 3% 4% 5% 6% 7% 8% Source: PHE/NDTMS, 213 (Partnership Quarter 1 (green) report/domes Q1 version 1 213/14 (for national comparisons)

8 GP shared care 212/13 A total of 18 clients were in GP Shared Care in 212/13. 1 in 1 (11%) of all clients completed treatment successfully 1 in 5 (2%) referred back to DASH Source: Drug Advisory Service, 212/13

9 GP shared care 212/13 This population is ageing: majority over 4 years of age. Source: Drug Advisory Service, 212/13

10 Young people Number in treatment: and England Q1 213/14, CYP aged Partnership 213/14 numbers in tx 212/13 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Still comparatively low numbers from Children and Families (CYPS) and CAMHS Numbers in treatment higher than in 212/13 Referral routes: and England Q1 213/14, CYP aged Children and Family Education Services Health and Mental Health Accident & Emergency Substance Misuse Services Youth Justice Services Family, Friends and Self YP Housing Provider Other Referral Source No Referral Source Percentage % 58% national Source: PHE/NDTMS, 213 (Young People local assurance report Q1 213/14)

11 Young people Planned exits: 213/14 Q1, and England Higher than national average for planned exits... Risk harm profile: 213/14 Q1, and England Percentage Score of 85% England 8%...and seemingly lower levels of need Score of 1 Score of 2 Score of 3 national Score of 4-1 Source: PHE/NDTMS, 213 (Young People local assurance report Q1 213/14)

12 Recovery s new integrated recovery focussed treatment system places emphasis on following outcomes: Freedom from dependence on drugs and alcohol Sustained employment Improvement in the capacity to be an effective and caring parent Improvement in mental and physical wellbeing The ability to access suitable accommodation Improved relationships with partners and friends A reduction in crime and offending Previous drug strategies focusing reducing crime and drug related harm this allowed a culture of commissioning and practise (which) gave insufficient priority to an individual s desire to overcome dependence Strang et al., 212:4),

13 Key actions Maintaining opiate users successful completions and improving non opiate users outcomes Preventing re-presentations Improvement in BBV testing and vaccination Re-tender of substance misuse services for young people in progress Bedding in newly commissioned adult treatment system Open up client choice through personalisation Build on and support peer led services and service user forum